CB

Christoph Bruecher

BA Biotest Ag: 14 patents #2 of 62Top 4%
IM Immunogen: 5 patents #34 of 119Top 30%
DI Dana-Farber Cancer Institute: 1 patents #698 of 1,343Top 55%
Overall (All Time): #348,951 of 4,157,543Top 9%
14
Patents All Time

Issued Patents All Time

Showing 1–14 of 14 patents

Patent #TitleCo-InventorsDate
10117932 Uses of immunoconjugates targeting CD138 Gregor Schulz, Frank Osterroth, Thomas Haeder, Gabriele Niemann, André Engling +7 more 2018-11-06
9995733 Agents for treating disease Frank Osterroth, Christoph Uherek, Benjamin Daelken, André Engling, Chantal Zuber +4 more 2018-06-12
9605066 Humanized anti-IL-10 antibodies for the treatment of systemic lupus erythematosus (SLE) Frank Osterroth, Christoph Uherek, Peter Röttgen, Benjamin Daelken, André Engling +5 more 2017-03-28
9550831 Method for treating psoriasis Silke Aigner, Matthias Germer, Frank Osterroth, Christoph Uherek, Elmar Kraus +6 more 2017-01-24
9540436 Use of antibodies for detection of IL-10 Frank Osterroth, Christoph Uherek, Peter Röttgen, Benjamin Daelken, André Engling +2 more 2017-01-10
9512226 Agent for treating disease Matthias Germer, Frank Osterroth, Silke Aigner, Christoph Uherek, Elmar Kraus +6 more 2016-12-06
9446146 Methods and agents for improving targeting of CD138 expressing tumor cells Benjamin Daelken, Christoph Uherek, Kenneth C. Anderson, Teru Hideshima, Frank Osterroth +2 more 2016-09-20
9387261 Immunoconjugates targeting CD138 and uses thereof Elmar Kraus, Benjamin Daelken, Steffen Zeng, Frank Osterroth, Christoph Uherek +4 more 2016-07-12
9334325 Method for treating psoriasis Frank Osterroth, Silke Aigner, Matthias Germer, Christoph Uherek, Elmar Kraus +5 more 2016-05-10
9289509 Uses of immunoconjugates targeting CD138 Frank Osterroth, Christoph Uherek, Benjamin Daelken, André Engling, Thomas Haeder +7 more 2016-03-22
9221914 Agents targeting CD138 and uses thereof Elmar Kraus, Benjamin Daelken, Matthias Germer, Steffen Zeng, Frank Osterroth +3 more 2015-12-29
9011864 Method of decreasing cytotoxic side-effects and improving efficacy of immunoconjugates Gregor Schulz, Frank Osterroth, Steffen Zeng, Christoph Uherek, Silke Aigner +3 more 2015-04-21
8956607 Humanized anti-IL 10 antibodies for the treatment of systemic lupus erythematosus (SLE) Frank Osterroth, Christoph Uherek, Peter Röttgen, Benjamin Daelken, André Engling +2 more 2015-02-17
8852871 Humanized anti-IL-10 antibodies for the treatment of systemic lupus erythematosus (SLE) Frank Osterroth, Christoph Uherek, Peter Röttgen, Benjamin Daelken, André Engling +5 more 2014-10-07